Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.52 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.52 |
| ▸ | VNN1 | O95497 | 8/20 | 0.52 |
| ▸ | GSK3B | P49841 | 2/20 | 0.50 |
| ▸ | PLAU | P00749 | 1/20 | 0.49 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60040 | 0.94 | MRGPRX4 (0.56) | CYP11B1CYP11B2MRGPRX4GSK3BPLAU | |
| SCHEMBL30444713 | 0.94 | MRGPRX4 (0.56) | CYP11B1CYP11B2MRGPRX4GSK3BPLAU | |
| SCHEMBL6578619 | 0.88 | CYP11B1 (0.55) | CYP11B1CYP11B2MRGPRX4GSK3BPLAU | |
| SCHEMBL2892627 | 0.85 | TSHR (0.61) | LOXL2 | |
| SCHEMBL7822720 | 0.84 | PLAU (0.61) | CYP11B1CYP11B2MRGPRX4GSK3BPLAU | |
| SCHEMBL3456924 | 0.84 | MRGPRX4 (0.52) | CYP11B1CYP11B2MRGPRX4GSK3BPLAU | |
| SCHEMBL16396165 | 0.83 | P4HB (0.63) | VNN1GSK3B | |
| SCHEMBL30874553 | 0.82 | ALDH1A1 (0.54) | VNN1GSK3B | |
| SCHEMBL29191014 | 0.82 | ALDH1A1 (0.54) | VNN1GSK3B | |
| SCHEMBL5928256 | 0.82 | RAB9A (0.52) | CYP11B1CYP11B2MRGPRX4PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040072866-A1 | Process for preparation of cyanophenylbenzoic acid derivatives | TEIJIN LIMITED (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1361213-A1 | PROCESS FOR PREPARATION OF CYANOPHENYLBENZOIC ACID DERIVATIVES | TEIJIN LIMITED (JP) | 2003-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040072866-A1 | Process for preparation of cyanophenylbenzoic acid derivatives | CCNY, ACLY, IWS1 | CYP11B1 1370/4885CYP11B2 1638/4885MRGPRX4 4364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.